199 related articles for article (PubMed ID: 37515143)
1. Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen-Fibrin Gels by Cytolytic and Non-Lytic Mechanisms.
Majumder B; Budhu S; Ganusov VV
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515143
[TBL] [Abstract][Full Text] [Related]
2. Mathematical modeling suggests cytotoxic T lymphocytes control growth of B16 tumor cells in collagin-fibrin gels by cytolytic and non-lytic mechanisms.
Majumder B; Budhu S; Ganusov VV
bioRxiv; 2023 Mar; ():. PubMed ID: 37034693
[TBL] [Abstract][Full Text] [Related]
3. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNγ-dependent cell-cycle arrest.
Matsushita H; Hosoi A; Ueha S; Abe J; Fujieda N; Tomura M; Maekawa R; Matsushima K; Ohara O; Kakimi K
Cancer Immunol Res; 2015 Jan; 3(1):26-36. PubMed ID: 25127875
[TBL] [Abstract][Full Text] [Related]
6. Dynamic visualization of the whole process of cytotoxic T lymphocytes killing B16 tumor cells in vitro.
Qi S; Shi H; Liu L; Zhou L; Zhang Z
J Biomed Opt; 2019 Mar; 24(5):1-7. PubMed ID: 30825298
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging data.
Beck RJ; Bijker DI; Beltman JB
PLoS Comput Biol; 2020 Jul; 16(7):e1007972. PubMed ID: 32658891
[TBL] [Abstract][Full Text] [Related]
8. Reduced CTL motility and activity in avascular tumor areas.
Manaster Y; Shipony Z; Hutzler A; Kolesnikov M; Avivi C; Shalmon B; Barshack I; Besser MJ; Feferman T; Shakhar G
Cancer Immunol Immunother; 2019 Aug; 68(8):1287-1301. PubMed ID: 31253998
[TBL] [Abstract][Full Text] [Related]
9. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
Verra NC; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; Weder P; Hooijberg E; Schumacher TN; Haanen JB; Spits H; Luiten RM
Cancer Res; 2004 Mar; 64(6):2153-61. PubMed ID: 15026357
[TBL] [Abstract][Full Text] [Related]
10. Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.
Lu D; Wang Y; Zhang T; Wang F; Li K; Zhou S; Zhu H; Yang Z; Liu Z
J Nanobiotechnology; 2021 Jun; 19(1):175. PubMed ID: 34112200
[TBL] [Abstract][Full Text] [Related]
11. Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression
Beck RJ; Slagter M; Beltman JB
Cancer Res; 2019 Jul; 79(13):3406-3416. PubMed ID: 31040155
[TBL] [Abstract][Full Text] [Related]
12. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
[TBL] [Abstract][Full Text] [Related]
13. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.
Nakagawa Y; Negishi Y; Shimizu M; Takahashi M; Ichikawa M; Takahashi H
Immunol Lett; 2015 Oct; 167(2):72-86. PubMed ID: 26209187
[TBL] [Abstract][Full Text] [Related]
14. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
15. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
[TBL] [Abstract][Full Text] [Related]
16. Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.
Gropper Y; Feferman T; Shalit T; Salame TM; Porat Z; Shakhar G
Cell Rep; 2017 Sep; 20(11):2547-2555. PubMed ID: 28903036
[TBL] [Abstract][Full Text] [Related]
17. A Sigmoid Functional Response Emerges When Cytotoxic T Lymphocytes Start Killing Fresh Target Cells.
Gadhamsetty S; Marée AFM; Beltman JB; de Boer RJ
Biophys J; 2017 Mar; 112(6):1221-1235. PubMed ID: 28355549
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma.
Chang ML; Chen YT; Su YC; Kung JT
J Biomed Sci; 2003; 10(6 Pt 1):644-50. PubMed ID: 14576467
[TBL] [Abstract][Full Text] [Related]
19. Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity.
Blakely A; Gorman K; Ostergaard H; Svoboda K; Liu CC; Young JD; Clark WR
J Exp Med; 1987 Oct; 166(4):1070-83. PubMed ID: 3498787
[TBL] [Abstract][Full Text] [Related]
20. c-Met
Benkhoucha M; Tran NL; Senoner I; Breville G; Fritah H; Migliorini D; Dutoit V; Lalive PH
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
